Smartshoes for Freezing of Gait in Parkinson's Disease
Trial
N/A
Not yet recruiting
May 7, 2026
Practical approaches to inclusive recruitment practices in Parkinson's disease research
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
May 7, 2026
Examining Sensory Systems That Contribute to Falls in Parkinson Disease Using Computerized Dynamic Posturography: Secondary Analysis.
Research
JMIR formative research
May 7, 2026
Frontal subcortical executive dysfunction and minor hallucinations in Parkinson's disease are linked to sensitivity to somatomotor conflicts
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
May 6, 2026
One world, one goal: Advocacy and policy for a unified Parkinson's response
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
May 6, 2026
Clinical GDNF delivery methods for Parkinson's disease
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
May 6, 2026
Closed-loop TMS for Tremor
Trial
N/A
Recruiting
May 6, 2026
O-ARM Stereotactic Imaging in Deep Brain Stimulation for Parkinson's Disease
Trial
N/A
Completed
May 6, 2026
Pathophysiology of Neuronal Oscillations Within Subthalamo-cortical Loops in Parkinson's Disease
Trial
N/A
Completed
May 6, 2026
Risk of Alzheimer Disease and Other Dementias in Patients With Parkinson Disease: A Nationwide Cohort Study.
Research
Alzheimer disease and associated disorders
May 6, 2026
Validation of remote multimodal AI screening for Parkinson disease across diverse settings.
Research
Communications medicine
May 6, 2026
The Use of 3D Printing Technology in Rehabilitation for Adults Living With Neurological Conditions: Scoping Review.
Research
JMIR rehabilitation and assistive technologies
May 6, 2026
Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)
Trial
N/A
Completed
May 5, 2026
Functional Neuroimaging in Parkinson's Disease
Trial
N/A
Completed
May 5, 2026
Effects of RAS on Gait in PD Patients With DBS
Trial
N/A
Recruiting
May 5, 2026
Combined Deep Brain Stimulation in Parkinson's Disease
Trial
N/A
Completed
May 5, 2026
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
Trial
Phase 3
Completed
May 5, 2026
Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry.
Research
Neurology
May 5, 2026
Four innovations to bridge the evidence-practice gap in Parkinson's disease allied health guidelines.
Research
Parkinsonism & related disorders
May 5, 2026